TLCR

Talecris Biotherapeutics Holdings Corp

Global biotherapeutics company developing, producing and distributing plasma-derived protein therapies for immunology, pulmonology (alpha-1 antitrypsin deficiency) and hemostasis/bleeding disorders

CUSIP: 874227101HealthcareUS1 holder

Ownership Activity Financials Filings

TLCR

Talecris Biotherapeutics Holdings Corp

Global biotherapeutics company developing, producing and distributing plasma-derived protein therapies for immunology, pulmonology (alpha-1 antitrypsin deficiency) and hemostasis/bleeding disorders

CUSIP: 874227101HealthcareUS1 holder

Ownership Activity Financials Filings

No insider transactions reported in the last year. Look across all recorded history →